TRAIL, 1st Edition

 
TRAIL, 1st Edition,Gerald Litwack,ISBN9780080522876
 
 
 

G Litwack   

Academic Press

9780080522876

448

This volume on TRAIL range from structure, biology, and biochemistry to the foundations for the use of TRAIL as a chemotherapeutic agent.

eBook
eBook Overview

VST format:

DRM Free included formats: PDF

USD 215.00
Add to Cart
 
 

Key Features

Selected Contents:
* Crystal Structure of RANK Ligand involved in bone metabolism
* Promoter of TRAIL-R2 Gene
* Monoclonal Antibodies against TRAIL
* Modulation of TRAIL signaling complex
* TRAIL in the airways
* FLIP Protein and TRAIL-Induced Apoptosis
* TRAIL and Ceramide
* TRAIL and Viral Infection
* TRAIL and Malignant Glioma

Description

The discovery of TRAIL (TNF Related Apoptosis Inducing Ligand), also referred to as Apo-2, is in an era of intense research because TRAIL induces many cancer cells to undergo programmed cell death (apoptosis), while having no effect on normal cells. This important protein deserves extensive review at a formative time in the devlopement of our knowledge concerning its mechanism of action and the ways in which it can be used as a cancer chemotherapeutic agent. Consequently, this voume reviews the current status of research on TRAIL.

Readership

Molecular biologists, cellular biologists, & biochemists

Gerald Litwack

Trained in biochemistry at the University of Wisconsin, Madison, Dr. Litwack worked on enzymology and the effects of hormones on enzyme systems. Then he was a Postdoctoral Fellow of the National Foundation for Infantile Paralysis at the Biochemical Institute of the Sorbonne in Paris. Dr. Litwack's first position was as Assistant Professor of Biochemistry at Rutgers University in 1954. Six years later, he joined the University of Pennsylvania as associate professor and four years later went to the Fels Institute for Cancer Research and Molecular Biology, as full professor, eventually becoming Deputy Director of the Institute. In 1991, he accepted the Chair of Pharmacology at Thomas Jefferson University where he is also Deputy Director of the Jefferson Cancer Institute and Associate Director for Basic Science in the Jefferson Cancer Center. Dr. Litwack's work has been in the area of mechanisms of steroid receptor action involving especially the glucocorticoid and mineralocorticoid receptors, immunophi.

Affiliations and Expertise

Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA

View additional works by Gerald Litwack
 
 

Shop with Confidence

Free Shipping around the world
▪ Broad range of products
▪ 30 days return policy
FAQ

Contact Us